Pro Share Advisors LLC Bridge Bio Pharma, Inc. Transaction History

Pro Share Advisors LLC

  • $42.5 Billion
  • Q4 2024

A detailed history of Pro Share Advisors LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 48,539 shares of BBIO stock, worth $1.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48,539
Previous 37,675 28.84%
Holding current value
$1.69 Million
Previous $959,000 38.79%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$22.35 - $29.5 $242,810 - $320,488
10,864 Added 28.84%
48,539 $1.33 Million
Q3 2024

Nov 13, 2024
BUY
$23.91 - $31.3 $251,007 - $328,587
10,498 Added 38.63%
37,675 $959,000
Q2 2024

Aug 13, 2024
SELL
$23.0 - $31.04 $140,392 - $189,468
-6,104 Reduced 18.34%
27,177 $688,000
Q1 2024

May 08, 2024
BUY
$27.35 - $40.45 $87,766 - $129,804
3,209 Added 10.67%
33,281 $1.03 Million
Q4 2023

Feb 14, 2024
BUY
$24.02 - $43.89 $109,747 - $200,533
4,569 Added 17.92%
30,072 $1.21 Million
Q3 2023

Nov 13, 2023
BUY
$16.89 - $35.01 $3,766 - $7,807
223 Added 0.88%
25,503 $672,000
Q2 2023

Aug 10, 2023
BUY
$13.29 - $18.01 $30,885 - $41,855
2,324 Added 10.12%
25,280 $434,000
Q1 2023

May 11, 2023
SELL
$7.17 - $18.55 $21,725 - $56,206
-3,030 Reduced 11.66%
22,956 $380,000
Q4 2022

Feb 02, 2023
BUY
$6.74 - $11.52 $13,378 - $22,867
1,985 Added 8.27%
25,986 $198,000
Q3 2022

Nov 04, 2022
SELL
$7.94 - $12.36 $8,090 - $12,594
-1,019 Reduced 4.07%
24,001 $239,000
Q2 2022

Aug 01, 2022
SELL
$5.21 - $12.14 $65,734 - $153,170
-12,617 Reduced 33.52%
25,020 $227,000
Q1 2022

May 10, 2022
SELL
$7.34 - $17.16 $65,825 - $153,890
-8,968 Reduced 19.24%
37,637 $381,000
Q4 2021

Feb 08, 2022
SELL
$11.38 - $53.41 $20,097 - $94,322
-1,766 Reduced 3.65%
46,605 $778,000
Q3 2021

Nov 12, 2021
SELL
$46.87 - $64.24 $298,702 - $409,401
-6,373 Reduced 11.64%
48,371 $2.27 Million
Q2 2021

Aug 13, 2021
BUY
$46.47 - $63.93 $409,958 - $563,990
8,822 Added 19.21%
54,744 $3.34 Million
Q1 2021

May 14, 2021
BUY
$55.47 - $72.35 $603,069 - $786,589
10,872 Added 31.02%
45,922 $2.83 Million
Q4 2020

Feb 09, 2021
BUY
$38.38 - $71.11 $245,785 - $455,388
6,404 Added 22.36%
35,050 $2.49 Million
Q3 2020

Nov 13, 2020
SELL
$27.2 - $42.19 $17,571 - $27,254
-646 Reduced 2.21%
28,646 $1.08 Million
Q2 2020

Aug 03, 2020
BUY
$22.22 - $35.69 $175,404 - $281,736
7,894 Added 36.89%
29,292 $955,000
Q1 2020

May 15, 2020
SELL
$16.11 - $36.23 $135,130 - $303,897
-8,388 Reduced 28.16%
21,398 $621,000
Q4 2019

Feb 12, 2020
BUY
$17.96 - $46.63 $534,956 - $1.39 Million
29,786 New
29,786 $1.04 Million

Others Institutions Holding BBIO

# of Institutions
315
Shares Held
177M
Call Options Held
11.2M
Put Options Held
2.29M
View Full List

About BridgeBio Pharma, Inc.

BBIO Quotes by TradingView
  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $5.17B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email